Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis

BACKGROUND: Bempedoic acid is an oral, once-daily, first-in-class drug being developed for the treatment of hyperlipidemia. However, evidence of bempedoic acid use for the prevention of cardiovascular events and diabetes is lacking. Thus, we aim to evaluate the benefit and safety of bempedoic acid u...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing, Zhang, Yu, Tan, Huiwen, Wang, Peng, Zha, Xi, Chong, Weelic, Zhou, Liangxue, Fang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425167/
https://www.ncbi.nlm.nih.gov/pubmed/32787939
http://dx.doi.org/10.1186/s12933-020-01101-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425167/
https://www.ncbi.nlm.nih.gov/pubmed/32787939
http://dx.doi.org/10.1186/s12933-020-01101-9

Ejemplares similares